Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LOSERT W")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 27

  • Page / 2
Export

Selection :

  • and

BIOLOGIE DER PROSTAGLANDINE UNTER BERUECKSICHTIGUNG THERAPEUTISCHER ASPEKTE = ASPECTS THERAPEUTIQUES DE LA BIOLOGIE DES PROSTAGLANDINESLOSERT W.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 2; PP. 135-148; ABS. ANGL.; BIBL. 1P. 1/2Article

GRUNDLAGEN DER PHARMAKOLOGIE ANTIDIABETISCH WIRKSAMER SUBSTANZEN. = LES PRINCIPES DE LA PHARMACOLOGIE DES SUBSTANCES AVEC UNE ACTIVITE ANTIDIABETIQUELOSERT W.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 7; PP. 422-433; BIBL. 2 P. 1/2Article

KLINISCH-PHARMAKOLOGISCHE UNTERSUCHUNGEN ZUR WIRKUNGSDAUER DES ORALEN ANTIDIABETIKUMS GLISOXEPID. = RECHERCHES DE PHARMACOLOGIE CLINIQUE SUR LA DUREE D'ACTION DE L'ANTIDIABETIQUE ORAL GLISOXEPIDEGUTSCHE H; LOSERT W.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 9; PP. 1719-1726; ABS. ANGL.; BIBL. 13 REF.Article

DETECTION AND COMPARATIVE EVALUATION OF ALDOSTERONE ANTAGONISTS IN GLUCOCORTICOID-TREATED, ADRENALECTOMIZED RATSCASALS STENZEL J; BUSE M; LOSERT W et al.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 80; NO 1; PP. 37-45; BIBL. 1 P.Article

IMPROVED METHOD FOR COMPARATIVE EVALUATION OF ALDOSTERONE ANTAGONISTS IN HEALTHY MAN.CASALS STENZEL J; SCHMALBACH J; LOSERT W et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 12; NO 4; PP. 247-255; BIBL. 32 REF.Article

EXPERIMENTELLE UNTERSUCHUNGEN ZUM MECHANISMUS DER DURCH SULFONYLHARNSTOFFE VERURSACHTEN HEMMUNG DER THROMBOZYTENAGGREGATION. I. PROBLEMSTELLUNG UND METHODEN = ETUDES EXPERIMENTALES SUR LE MECANISME DE L'INHIBITION DE L'AGREGATION PLAQUETTAIRE PAR LES SULFONYLUREES. I. PRESENTATION DU PROBLEME ET METHODESSCHOLZ C; LOSERT W; HODER A et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 1; PP. 38-46Article

APPLICATION OF REGRESSION ANALYSIS TO THE HYPOGLYCEMIC ACTIVITIES OF A SERIES OF SUBSTITUTED BENZENESULFONAMIDOPYRIMIDINESSEYDEL JK; AHRENS H; LOSERT W et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 3; PP. 234-240; BIBL. 30REF.Article

COMPARISON OF THE VASODEPRESSOR ACTION OF ZK 36374, A STABLE PROSTACYCLIN DERIVATIVE, PGI2 AND PGE1 WITH THEIR EFFECT ON PLATELET AGGREGATION AND BLEEDING TIME IN RATSCASALS STENZEL J; BUSE M; LOSERT W et al.1983; PROSTAGLANDINS, LEUKOTRIENES AND MEDICINE; ISSN 0262-1746; GBR; DA. 1983; VOL. 10; NO 2; PP. 197-212; BIBL. 25 REF.Article

Zur Kenntnis der K4[Ag4O4]-Verwandtschaft = A propos de la relation K4[Ag4O4] = On the K4[Ag4O4] relationLOSERT, W; HOPPE, R.Zeitschrift für anorganische und allgemeine Chemie (1950). 1985, Vol 524, pp 7-16, issn 0044-2313Article

Zur Kenntnis von Li2[CuO2] = Connaissance de Li2[CuO2] = On Li2[CuO2]LOSERT, W; HOPPE, R.Zeitschrift für anorganische und allgemeine Chemie (1950). 1984, Vol 515, pp 95-100, issn 0044-2313Article

Das erste Oxocuprat(I) mit hantelförmigem Anion: KNa2[CuO2] = Le premier oxocuprate(I) avec anion en forme dhaltère: KNa2[CuO2] = The first oxocuprate(I) with dumbbell-like anion: KNa2[CuO2]LOSERT, W; HOPPE, R.Zeitschrift für anorganische und allgemeine Chemie (1950). 1984, Vol 515, pp 87-94, issn 0044-2313Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR WIRKUNGSWEISE DER BIGUANIDE. III. VERSUCHE MIT NICHT HYPOGLYKAEMISCH WIRKENDEN BIGUANIDDOSEN = RECHERCHES EXPERIMENTALES SUR L'ANIMAL SUR LE MODE D'ACTION DES BIGUANIDES. III. RECHERCHES AVEC DES DOSES DE BIGUANIDES NE PRESENTANT PAS D'ACTIVITE HYPOGLYCEMIANTELOSERT W; SCHILLINGER E; KRAAZ W et al.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 9; PP. 1540-1552; BIBL. 7 REF.Serial Issue

Neue Oxocuprate (I) Über Cs3Cu5O4, Rb2KCu5O4, RbK2Cu5O4 und K3Cu5O4 = De nouveaux oxocuprates (I). Au sujet de Cs3Cu5O4, Rb2KCu5O4, RbK2Cu5O4 et K3Cu5O4 = New oxocuprates (I). On Cs3Cu5O4, Rb2KCu5O4, RbK2Cu5O4, and K3Cu5O4HOPPE, R; LOSERT, W.Zeitschrift für anorganische und allgemeine Chemie (1950). 1983, Vol 504, pp 60-66, issn 0044-2313Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR WIRKUNGSWEISE DER BIGUANIDE. III. VERSUCHE MIT NICHT HYPOGLYKAEMISCH WIRKENDEN BIGUANIDDOSEN = RECHERCHES EXPERIMENTALES SUR L'ANIMAL SUR LE MODE D'ACTION DES BIGUANIDES. III. RECHERCHES AVEC DES DOSES DE BIGUANIDES NE PRESENTANT PAS D'ACTIVITE HYPOGLYCEMIANTELOSERT W; SCHILLINGER E; KRAAZ W et al.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 9; PP. 1540-1552; BIBL. 7 REF.Serial Issue

Local control of the dendritic microstructure through perturbationLEE, K; LOSERT, W.Journal of crystal growth. 2004, Vol 269, Num 2-4, pp 592-598, issn 0022-0248, 7 p.Article

Ein neues Oxocuprat(I): K3[CuO2] = Un nouvel oxocuprate(I): K3 [CuO2] = A new oxocuprate(I): K3 [CuO2]LOSERT, W; HOPPE, R.Zeitschrift für anorganische und allgemeine Chemie (1950). 1985, Vol 521, pp 69-78, issn 0044-2313Article

GLIFLUMIDE, A NEW ORAL ANTIDIABETIC OF HIGH POTENCY AND EFFICACY.BLUMENBACH L; GERHARDS E; GUTSCHE H et al.1975; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1975; VOL. 12; NO 1-2; PP. 141-151; BIBL. 10 REF.; (VITH INT. SYMP. CLIN. PHARMACOL.; REGENSBURG, GER.; 1974)Conference Paper

Progestogens with antimineralocorticoid activityLOSERT, W; CASALS-STENZEL, J; BUSE, M et al.Arzneimittel-Forschung. 1985, Vol 35, Num 2, pp 459-471, issn 0004-4172Article

Granular memory and its effect on the triggering and distribution of rock avalanche eventsFRIEDMANN, S. J; KWON, G; LOSERT, W et al.Journal of geophysical research. 2003, Vol 108, Num B8, pp ECV8.1-ECV8.11, issn 0148-0227Article

Control of eutectic solidification microstructures through laser spot perturbationsAKAMATSU, S; LEE, K; LOSERT, W et al.Journal of crystal growth. 2006, Vol 289, Num 1, pp 331-338, issn 0022-0248, 8 p.Article

The renal action of spirorenone and other 6β,7β; 15β,16β-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonistsCASALS-STENZEL, J; BUSE, M; WAMBACH, G et al.Arzneimittel-Forschung. 1984, Vol 34, Num 3, pp 241-246, issn 0004-4172Article

Dendritic sidebranching with periodic localized perturbations : directional solidification of pivalic acid-coumarin 152 mixturesWILLIAMS, L. M; MUSCHOL, M; QIAN, X et al.Physical review. A. 1993, Vol 48, Num 1, pp 489-499, issn 1050-2947, EArticle

Shape dynamics of lipid vesicles forced by holographic optical tweezersPOOLE, C; MESZAROS, J; LOSERT, W et al.Proceedings of SPIE, the International Society for Optical Engineering. 2006, pp 63261L.1-63261L.8, issn 0277-786X, isbn 0-8194-6405-8Conference Paper

Aldosterone antagonists. III: Synthesis and activities of steroidal 7α-(alkoxycarbonyl)-15,16-methylene spiroldactonesNICKISCH, K; BITTLER, D; LAURENT, H et al.Journal of medicinal chemistry (Print). 1990, Vol 33, Num 2, pp 509-513, issn 0022-2623Article

Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonistsLOSERT, W; BITTLER, D; BUSE, M et al.Arzneimittel-Forschung. 1986, Vol 36, Num 11, pp 1583-1600, issn 0004-4172Article

  • Page / 2